September 2025 A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH
November 2021 Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
September 2025 Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
August 2021 New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
FibroScan®
